White Paper
Pharmaceutical Counterfeiting — A Clear And Present Danger
Click Here To Download:
•White Paper: Pharmaceutical Counterfeiting — A Clear And Present Danger
By Donald J. Dobert, President and COO, ATL
Pharmaceutical counterfeiting is the perfect crime. The "drug supply channel" is ill equipped to prevent it. Counterfeiting is a dangerous and growing problem. The number of counterfeiting "attacks" are on the rise, the products targeted are on the increase, and the techniques are becoming more sophisticated.
Summarized in this white paper are four examples of the counterfeiter's "modus operandi":
1. Repackaging. One of the largest counterfeiting attacks known involved more than 18 million doses of counterfeit Lipitor (a cholesterol lowering drug). Counterfeiters manufactured the tablets (that had some of the active ingredients). Bulk containers of the fakes were imported into the United States, emptied, filled with a different product, and then exported. At the same time, the counterfeit Lipitor was repackaged by an "assumed" legitimate company, then sold into the regular wholesale distribution chain.
Click Here To Download:•White Paper: Pharmaceutical Counterfeiting — A Clear And Present Danger
